One person dies each day in Washington considering he or she doesn’t have health insurance, says a new report by Families USA, the national organization for health care consumers. The Families USA report, the first-ever state-specific report of that type, is based on a groundbreaking national...

In the first external analysis of the California department of Health Service’s Medi-Cal Managed Care program, researchers from the UCLA office of Family Medicine found widespread health care disparities based on ethnicity, race and language all through the system.And African Americans are bearing...

For a lengthy duration, scientists believed that the immune system acted to fight cancer development. However, recent findings demonstrate that the immune system additionally acts to promote cancer progression. At the worldly conference “Invasion and Metastasis” held at the Max Delbrück...

Another day, another exoskeleton. Designed to help paraplegics to walk again, ReWalk™ is the product of Israeli company Argo Medical Technologies, Ltd. Massachusetts based SolidWorks Corp, whose 3D CAD software was used to develop the device, is reporting about the exoskeleton: An innovative alternative...

U.S. Food and Drug Administration Commissioner Andrew C. von Eschenbach announced that the agency has issued draft guidelines to aid the development, evaluating and manufacture of coronary drug-eluting stents, devices used to treat blocked heart arteries. by the past few years, FDA and the clinical community...

The American Diabetes organization (ADA) and the American College of Cardiology (ACC) issued a consensus statement that states the measurement of LDL particle number by nuclear magnetic resonance (NMR) is one of the more accurate ways to to assess cardiometabolic risk (CMR). The study, published in the...

UCB announces first results of its phase II exploratory study of CDP791, a specific VEGFR-2/KDR inhibitor, in combination with carboplatin and paclitaxel chemotherapy in first line non-small cell lung cancer (NSCLC). Positive improvements were observed on several efficacy endpoints including tumour...

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) and collaborators nationwide have found that decreased sexual satisfaction in postmenopausal women, is not clearly associated with cardiovascular disease. that study appears in the April 2008 issue of The American...

A randomized clinical trial comparing the Conor Sirolimus-eluting Coronary Stent, a new cobalt chromium reservoir-base stent design, to the Taxus Liberte Paclitaxel-eluting Coronary Stent has begun according to Conor Medsystems, LLC and Cordis Corporation, the sponsors of the study. “We are...

Results of ENHANCE (Ezetimibe aNd simvastatin in Hypercholesterolemia enhANces atherosClerosis rEgression), an imaging trial in 720 patients with heterozygous familial hypercholesterolemia (HeFH), a rare genetic condition that causes very high levels of LDL “bad” cholesterol and greatly increases Original...

The academic leadership of the IMPROVE-IT trial recommended increasing the size of the patient population up to 18,000. Merck/Schering-Plough Pharmaceuticals, sponsor of the study, agreed with the recommendation. With the increase in enrollment, the current estimate for the completion of the trial...